Featured Research

from universities, journals, and other organizations

Gore-tex-type Device Designed To Stop Strokes And Mini-strokes

Date:
November 18, 2008
Source:
Rush University Medical Center
Summary:
A study is under way at Rush University Medical Center using a small, soft-patch device made of a Gore-tex-type material -- often used to make durable outerwear -- to close a common hole found in the heart called a patent foramen ovale in order to prevent recurrent strokes and transient ischemic attacks in adults.

A study is under way at Rush University Medical Center using a small, soft-patch device made of a Gore-tex-type material – often used to make durable outerwear – to close a common hole found in the heart called a patent foramen ovale (PFO) in order to prevent recurrent strokes and transient ischemic attacks (TIAs) in adults.

Rush is the only academic medical center in the Chicago area involved in the trial and one of only 50 sites in the U.S. and the world.

The randomized, multinational clinical research trial may determine if repairing a PFO using this device, also known as the GORE HELEX Septal Occluder, is more effective in preventing strokes than medical management alone. The U.S. Food and Drug Administration (FDA) recently granted approval to use the device for PFO closures. It is currently approved by the FDA for the treatment of atrial septal defects (ASDs), a congenital heart defect found in young children.

“This PFO-closure device uses a biocompatible material that allows progressive tissue growth to help seal the defect,” Dr. Ziyad Hijazi, director of the Rush Center for Congenital and Structural Heart Disease and co-investigator of the clinical trial at Rush. “It shows promise because of its soft, flexible design that has the ability to conform to a patient’s anatomy.”

The miniature umbrella-like device is fed through a catheter that is placed in the vein of the patient’s leg using just one small puncture. The catheter is led through the vein up to the heart where the device is placed to seal the flap.

“Everyone is born with a PFO, which normally closes after birth “said Hijazi. “But in one in five Americans, the closure process is incomplete allowing blood returning from the body to bypass the filtering system of the lungs and enabling blood clots to travel from one area of the body through the heart and up to the brain causing a stroke.”

Most often, patients do not show any signs or symptoms, and a PFO can go undetected through adulthood. It is not until a patient experiences a stroke that a PFO defect is often diagnosed. Many of these strokes occur in people under the age of 50.

“Stroke has many causes. Unfortunately, in approximately twenty-five percent of cases, we do not find a specific cause. It has been suggested that in these cases, which are referred to as cryptogenic stroke, PFO might be a potential risk factor,” said Dr. Vivien Lee, stroke neurologist and study co-investigator at Rush. “The question we are trying to answer with this study is whether a PFO closure can reduce the risk of recurrent stroke.”

The purpose of the study is to help patients like Nathan Prince, a 31-year-old truck driver from Justice, Ill., who learned he had a congenital hole in his heart after suffering two strokes in three days.

“I was completely shocked,” said Prince. “I kept thinking I am way too young. I never experienced any symptoms. I am pretty athletic and always on the go. All of this seemed so sudden.”

Prince was immediately put on anticoagulants and other medication. “I was pretty upset when I found out that I had to take all this medication,” said Prince. “I mean, I am a young guy and now I have to take all these medicines and who knows what the long term effects could be.”

Prince’s neurologist referred him to Rush University Medical Center to see Hijazi. “When Dr. Hijazi explained to me that I could have a procedure that could close up that hole, stop my stroke symptoms and be home the next day, I immediately asked how soon we could do the procedure,” said Prince.

The same afternoon as his procedure, Nathan was up, reading, moving around and ready to go home.

“I’m just happy that I won’t have to be on all those medications anymore,” said Prince.

Currently, the primary treatment option is medical management.

“This study may provide useful information that will help us determine a new possible standard of care for stroke patients,” said Lee. “We have medications options that work well in reducing a stroke patient’s risk of recurrence, but now we can see if PFO closure is an additional option that may also be beneficial to stroke patients.

MRI-imaging will be performed on all patients as a baseline in order to make comparisons between treatment arms.

To participate in the study, you must be 18-60-years-old, have a presence of a PFO with a history of cryptogenic stroke or imaging-confirmed TIA. To enroll in the study, contact Catherine Glase at 312-942-9398.


Story Source:

The above story is based on materials provided by Rush University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Rush University Medical Center. "Gore-tex-type Device Designed To Stop Strokes And Mini-strokes." ScienceDaily. ScienceDaily, 18 November 2008. <www.sciencedaily.com/releases/2008/11/081118131855.htm>.
Rush University Medical Center. (2008, November 18). Gore-tex-type Device Designed To Stop Strokes And Mini-strokes. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/11/081118131855.htm
Rush University Medical Center. "Gore-tex-type Device Designed To Stop Strokes And Mini-strokes." ScienceDaily. www.sciencedaily.com/releases/2008/11/081118131855.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins